Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells

References

• Salemme FR. Structure and function of cytochromes c. Annu Rev Biochem 1977;46:299–329
   PubMed Web of Science ®Google Scholar
• Cao X, Bennett RL, May WS. c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis. J Biol Chem 2008;283:14490–6
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309–12
   PubMed Web of Science ®Google Scholar
• Jurgensmeier JM, Xie Z, Deveraux Q, et al. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998;95:4997–5002
   PubMed Web of Science ®Google Scholar
• Rosse T, Olivier R, Monney L, et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 1998;391:496–9
   PubMed Web of Science ®Google Scholar
• Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010;11:621–32
   PubMed Web of Science ®Google Scholar
• Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205–19
   PubMed Web of Science ®Google Scholar
• Dubrez-Daloz L, Dupoux A, Cartier J. IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 2008;7:1036–46
   PubMed Web of Science ®Google Scholar
• Kenien R, Shen WC, Zaro JL. Vesicle-to-cytosol transport of disulfide-linked cargo mediated by an amphipathic cell-penetrating peptide. J Drug Target 2012;20:793–800
   PubMed Web of Science ®Google Scholar
• Kim SK, Foote MB, Huang L. The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles. Biomaterials 2012;33:3959–66
   PubMed Web of Science ®Google Scholar
• Santra S, Kaittanis C, Perez JM. Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy. Mol Pharm 2010;7:1209–22
   PubMed Web of Science ®Google Scholar
• Alcala-Alcala S, Urban-Morlan Z, Aguilar-Rosas I, Quintanar-Guerrero D. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process. Int J Nanomed 2013;8:2141–51
   PubMed Web of Science ®Google Scholar
• Furuhata M, Kawakami H, Toma K, et al. Intracellular delivery of proteins in complexes with oligoarginine-modified liposomes and the effect of oligoarginine length. Bioconjug Chem 2006;17:935–42
   PubMed Web of Science ®Google Scholar
• Yoon HY, Lee SH, Cho SW, et al. TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells. Neurochem Int 2002;41:37–42
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 2007;59:748–58
   PubMed Web of Science ®Google Scholar
• Fonseca SB, Pereira MP, Kelley SO. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev 2009;61:953–64
   PubMed Web of Science ®Google Scholar
• Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J 2012;14:282–95
   PubMed Web of Science ®Google Scholar
• Medina SH, Tekumalla V, Chevliakov MV, et al. N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers. Biomaterials 2011;32:4118–29
   PubMed Web of Science ®Google Scholar
• Prakash J, De Jong E, Post E, et al. A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier. J Control Release 2010;145:91–101
   PubMed Web of Science ®Google Scholar
• Lammers T. Smart drug delivery systems: back to the future vs. clinical reality. Int J Pharm 2013;454:527–9
   PubMed Web of Science ®Google Scholar
• Trere D, Fiume L, De Giorgi LB, et al. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells. Br J Cancer 1999;81:404–8
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 2012;157:168–82
   PubMed Web of Science ®Google Scholar
• Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 2008;132:171–83
   PubMed Web of Science ®Google Scholar
• Kratz F, Beyer U. Serum proteins as drug carriers of anticancer agents: a review. Drug Deliv 1998;5:281–99
   PubMed Web of Science ®Google Scholar
• Regino CA, Ogawa M, Alford R, et al. Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis. J Med Chem 2010;53:1579–86
   PubMed Web of Science ®Google Scholar
• Kasibhatla S, Amarante-Mendes GP, Finucane D, et al. Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. Cold Spring Harbour Protocols; 2006. doi: 10.1101/pdb.prot4493
   Google Scholar
• Wu J, Yi W, Jin L, et al. Antiproliferative and cell apoptosis-inducing activities of compounds from Buddleja davidii in Mgc-803 cells. Cell Div 2012;7:20. doi: 10.1186/1747-1028-7-20
   PubMed Web of Science ®Google Scholar
• Holtsberg FW, Ensor CM, Steiner MR, et al. Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties. J Control Release 2002;80:259–71
   PubMed Web of Science ®Google Scholar
• Wunder A, Muller-Ladner U, Stelzer EH, et al. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. J Immunol 2003;170:4793–801
   PubMed Web of Science ®Google Scholar
• Ge J, Neofytou E, Lei J, et al. Protein-polymer hybrid nanoparticles for drug delivery. Small 2012;8:3573–8
   PubMed Web of Science ®Google Scholar
• Huang YS, Chen Z, Yang ZY, et al. Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-alpha2b fusion protein expressed in Pichia pastoris. Eur J Pharm Biopharm 2007;67:301–8
   PubMed Web of Science ®Google Scholar
• Simoni A, Pellegrini M, Cecconi C, Pellegrino M. Axotomy affects density but not properties of potassium leak channels, in the leech AP neurons. Brain Res 1990;522:118–24
   PubMed Web of Science ®Google Scholar
• Barnes MP, Shen WC. Disulfide and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells. Int J Pharm 2009;369:79–84
   PubMed Web of Science ®Google Scholar
• Biaglow JE, Donahue J, Tuttle S, et al. A method for measuring disulfide reduction by cultured mammalian cells: relative contributions of glutathione-dependent and glutathione-independent mechanisms. Anal Biochem 2000;281:77–86
   PubMed Web of Science ®Google Scholar
• Chen YJ, Su JH, Tsao CY, et al. Sinulariolide induced hepatocellular carcinoma apoptosis through activation of mitochondrial-related apoptotic and PERK/eIF2alpha/ATF4/CHOP pathway. Molecules 2013;18:10146–61
   PubMed Web of Science ®Google Scholar
• Zhang H, Ozaki I, Mizuta T, et al. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 2006;25:6101–12
   PubMedGoogle Scholar
• Kurmyshkina O, Rapoport E, Moiseeva E, et al. Glycoprobes as a tool for the study of lectins expressed on tumor cells. Acta Histochem 2010;112:118–26
   PubMed Web of Science ®Google Scholar
• David A, Kopeckova P, Kopecek J, Rubinstein A. The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells. Pharm Res 2002;19:1114–22
   PubMed Web of Science ®Google Scholar
• Hama Y, Urano Y, Koyama Y, et al. Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. Biochem Biophys Res Commun 2006;348:807–13
   PubMed Web of Science ®Google Scholar
• Yao Z, Zhang M, Sakahara H, et al. Imaging of intraperitoneal tumors with technetium-99m GSA. Annu Nucl Med 1998;12:115–18
   PubMedGoogle Scholar
• Li Y, Huang G, Diakur J, Wiebe LI. Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development. Curr Drug Deliv 2008;5:299–302
   PubMedGoogle Scholar
• Schafer ZT, Parrish AB, Wright KM, et al. Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells. Cancer Res 2006;66:2210–18
   PubMed Web of Science ®Google Scholar
• Soengas MS, Capodieci P, Polsky D, et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001;409:207–11
   PubMed Web of Science ®Google Scholar
• Wolf BB, Schuler M, Li W, et al. Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem 2001;276:34244–51
   PubMed Web of Science ®Google Scholar